论文信息 - Comparing RECIST 1.1 and iRECIST in advanced melanoma patients treated with pembrolizumab in a phase II clinical trial - 字舞流文

Comparing RECIST 1.1 and iRECIST in advanced melanoma patients treated with pembrolizumab in a phase II clinical trial

L. Schwartz | Binsheng Zhao | M. Maitland | C. Robert | R. Carvajal | L. Dercle | F. Ahmed | G. Oxnard | Hao Yang | G. Goldmacher | S. Karovic | Ying Tang | Dana E. Connors